Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 3Terminated 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Sleep Apnea, Obstructive 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Estrogens × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

NCT01428245 2020-12-30

JCM026

University of Virginia

Phase NA Terminated
3 enrolled 4 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡